{"id":"W2987820141","doi":"10.1097/md.0000000000017748","title":"Efficacy and safety of abiraterone and enzalutamide for castration-resistant prostate cancer","year":2019,"lang":"en","type":"review","venue":"Medicine","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":16,"is_retracted":false,"has_abstract":true,"ca_institutions":"Office of the Chief Medical Examiner","funders":"National Key Research and Development Program of China; Department of Science and Technology of Sichuan Province; National Natural Science Foundation of China","keywords":"Medicine; Enzalutamide; Prostate cancer; Hazard ratio; Adverse effect; Internal medicine; Randomized controlled trial; Urology; Oncology; Abiraterone; Cancer; Confidence interval; Androgen receptor","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003532131,0.0003257319,0.001939194,0.00019871,0.00005714736,0.000007715613,0.00005921516,0.0001563152,0.00007081394],"category_scores_gemma":[0.0001037451,0.0001847875,0.00008237948,0.0001793949,0.0003405243,0.00003412526,0.0000404187,0.000212081,0.00000219512],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001284515,"about_ca_system_score_gemma":0.0005097301,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0001399978,"about_ca_topic_score_gemma":0.00002210547,"domain_scores_codex":[0.9983451,0.00004918021,0.0006180647,0.0004216748,0.0002790831,0.0002868741],"domain_scores_gemma":[0.9988111,0.000333812,0.0002577183,0.0002702453,0.0001501706,0.0001770148],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.001557806,0.00005544716,0.00008980156,0.08321429,0.0005157011,0.00002237248,0.0003406444,1.221458e-7,0.0003003163,0.00005448037,0.0009329453,0.9129161],"study_design_scores_gemma":[0.009510379,0.001945983,0.0005484315,0.04431554,0.002942036,0.00004237887,0.00005647671,0.000005040074,0.00004469238,0.00001435167,0.9403939,0.0001808541],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.0008813642,0.9929127,0.000005662594,0.001009269,0.0001497142,0.004553332,0.0002732503,0.00001515114,0.0001995591],"genre_scores_gemma":[0.000338431,0.9940436,0.00008721554,0.00004109274,0.0002616029,0.0003189674,0.0003952836,0.00005006462,0.004463778],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.9394609,"threshold_uncertainty_score":0.7535416,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.1090050402307738,"score_gpt":0.4317681291000279,"score_spread":0.3227630888692541,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}